Orphazyme A/S Stock Forecast

Orphazyme A/S stock upgraded from Sell Candidate to Hold/Accumulate after Thursday trading session.
(Updated on Apr 25, 2024)

ORPHA.CO Signals & Forecast

A buy signal was issued from a pivot bottom point on Monday, April 22, 2024, and so far it has risen 9.45%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Orphazyme A/S has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Orphazyme A/S stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at kr1,147.78. On a fall, the stock will find some support from the short-term average at kr1,067.29. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal.

Support, Risk & Stop-loss for Orphazyme A/S stock

On the downside, the stock finds support just below today's level from accumulated volume at kr993.80 and kr973.90. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Orphazyme A/S finds support just below today's level at kr993.80. If this is broken, then the next support from accumulated volume will be at kr973.90 and kr969.80.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved kr45.00 between high and low, or 4.27%. For the last week, the stock has had daily average volatility of 8.82%.

Our recommended stop-loss: kr1,056.00 (-4.00%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 3 days ago.)

Trading Expectations (ORPHA.CO) For The Upcoming Trading Day Of Friday 26th

For the upcoming trading day on Friday, 26th we expect Orphazyme A/S to open at kr1,085.00, and during the day (based on 14 day Average True Range), to move between kr1,020.53 and kr1,179.47, which gives a possible trading interval of +/-kr79.47 (+/-7.22%) up or down from last closing price. If Orphazyme A/S takes out the full calculated possible swing range there will be an estimated 14.45% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at kr993.80 (9.65%) than the resistance at kr1,249.80 (13.62%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Orphazyme A/S stock A Buy?

Orphazyme A/S holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.

Current score: -0.901 Hold/Accumulate Upgraded

Predicted Opening Price for Orphazyme A/S of Friday, April 26, 2024

The predicted opening price is based on yesterday's movements between high, low, and closing price.